Auto-generated challenge from hypothesis h-881bc290 (score=0.858). Target: NAMPT. Question: Can targeting TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger lead to therapeutic benefit in neurodegeneration? Falsifiable prediction: Metabolic reprogramming will restore cellular energetics and reduce senescence markers.